Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.49% |
| 2 | Consumer Discretionary | 16.46% |
| 3 | Healthcare | 15.81% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
American Electric Power
AEP
$66.6B
| $321M | 0.3% |
4,534,740
+226,044
| +5% | +$16.1M |
|
52
Exelon
EXC
$45.3B
| $321M | 0.3% |
10,320,091
+214,319
| +2% | +$6.6M |
|
53
Centene
CNC
$32B
| $289M | 0.27% |
3,997,758
-228,294
| -5% | -$15.9M |
|
54
Merck
MRK
$366B
| $265M | 0.24% |
3,907,866
+2,938,523
| +303% | +$187M |
|
55
EOG Resources
EOG
$75.2B
| $263M | 0.24% |
2,059,853
-52,740
| -2% | -$6.41M |
|
56
Edwards Lifesciences
EW
$52B
| $251M | 0.23% |
4,333,152
+1,796,205
| +71% | +$87.8M |
|
57
Crown Castle
CCI
$32.4B
| $242M | 0.22% |
2,171,335
+1,711,765
| +372% | +$191M |
|
58
Mondelez International
MDLZ
$79.6B
| $230M | 0.21% |
5,362,764
+390,505
| +8% | +$16.7M |
|
59
Eli Lilly
LLY
$1.05T
| $230M | 0.21% |
2,144,546
+242,577
| +13% | +$24.3M |
|
60
Bank of America
BAC
$436B
| $229M | 0.21% |
7,768,357
-893,662
| -10% | -$27.2M |
|
61
Cheniere Energy
LNG
$58.3B
| $226M | 0.21% |
3,252,467
+1,887,892
| +138% | +$122M |
|
|
WPX
62
DELISTED
WPX Energy, Inc.
WPX
| $224M | 0.21% |
11,138,098
-301,996
| -3% | -$5.6M |
|
|
NBL
63
DELISTED
Noble Energy, Inc.
NBL
| $224M | 0.21% |
7,167,256
-586,807
| -8% | -$18.8M |
|
64
Abbott
ABT
$195B
| $223M | 0.21% |
3,042,872
+276,355
| +10% | +$18.1M |
|
65
Pfizer
PFE
$159B
| $221M | 0.2% |
5,290,802
+741,504
| +16% | +$28.5M |
|
|
66
Monster Beverage
MNST
$91.8B
| $220M | 0.2% |
15,101,532
-27,098,744
| -64% | -$408M |
|
67
NextEra Energy
NEE
$171B
| $206M | 0.19% |
4,916,204
-13,608
| -0.3% | -$579K |
|
|
RDS.A
68
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $203M | 0.19% |
2,982,340
-94,163
| -3% | -$6.29M |
|
69
Targa Resources
TRGP
$61.7B
| $202M | 0.19% |
3,591,035
+540,140
| +18% | +$28.8M |
|
70
Pinnacle Financial Partners Inc
PNFP
$15.3B
| $201M | 0.18% |
3,338,485
-163,335
| -5% | -$10.3M |
|
71
Sarepta Therapeutics
SRPT
$2.2B
| $197M | 0.18% |
1,219,503
+5,604
| +0.5% | +$766K |
|
72
Walmart Inc
WMT
$820B
| $190M | 0.18% |
6,083,658
-124,536
| -2% | -$3.81M |
|
73
Shopify
SHOP
$197B
| $190M | 0.17% |
11,552,110
+8,709,530
| +306% | +$133M |
|
74
Truist Financial
TFC
$61.6B
| $189M | 0.17% |
3,893,699
-507,398
| -12% | -$26M |
|
75
Williams Companies
WMB
$90.2B
| $187M | 0.17% |
6,864,215
+2,152,023
| +46% | +$62.4M |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.